X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (71) 71
female (55) 55
adult (53) 53
middle aged (53) 53
oncology (52) 52
aged (43) 43
male (43) 43
pharmacology & pharmacy (30) 30
neoplasms - drug therapy (25) 25
pharmacokinetics (24) 24
chemotherapy (22) 22
dose-response relationship, drug (18) 18
cancer (16) 16
drug administration schedule (16) 16
paclitaxel - administration & dosage (16) 16
antineoplastic agents - adverse effects (15) 15
infusions, intravenous (15) 15
ovarian neoplasms - drug therapy (15) 15
paclitaxel (15) 15
paclitaxel - pharmacokinetics (14) 14
antineoplastic agents - pharmacokinetics (13) 13
antineoplastic agents - therapeutic use (13) 13
area under curve (13) 13
cisplatin (13) 13
administration, oral (12) 12
topotecan (12) 12
taxol (11) 11
antineoplastic agents, phytogenic - pharmacokinetics (10) 10
carboplatin (10) 10
therapy (10) 10
trial (10) 10
antineoplastic agents, phytogenic - administration & dosage (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
drug evaluation (9) 9
mice (9) 9
ovarian-cancer (9) 9
paclitaxel - adverse effects (9) 9
treatment outcome (9) 9
breast neoplasms - drug therapy (8) 8
camptothecin (8) 8
camptothecin - analogs & derivatives (8) 8
cisplatin - administration & dosage (8) 8
cisplatin - adverse effects (8) 8
index medicus (8) 8
animals (7) 7
antineoplastic agents - administration & dosage (7) 7
antineoplastic agents, phytogenic - adverse effects (7) 7
camptothecin - pharmacokinetics (7) 7
infusion (7) 7
lung neoplasms - drug therapy (7) 7
neoplasms - metabolism (7) 7
performance liquid-chromatography (7) 7
pharmacodynamics (7) 7
phase-i (7) 7
prognosis (7) 7
thrombocytopenia - chemically induced (7) 7
antineoplastic combined chemotherapy protocols - pharmacokinetics (6) 6
biological availability (6) 6
camptothecin - adverse effects (6) 6
cremophor el (6) 6
cyclosporine - administration & dosage (6) 6
nonlinear pharmacokinetics (6) 6
ovarian cancer (6) 6
p-glycoprotein (6) 6
paclitaxel - therapeutic use (6) 6
survival analysis (6) 6
time factors (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
camptothecin - administration & dosage (5) 5
half-life (5) 5
injections, intravenous (5) 5
metabolism (5) 5
neutropenia - chemically induced (5) 5
ovarian neoplasms - mortality (5) 5
prospective studies (5) 5
topoisomerase i inhibitors (5) 5
topotecan - pharmacokinetics (5) 5
toxicity (5) 5
adenocarcinoma - drug therapy (4) 4
adolescent (4) 4
antineoplastic agents, phytogenic - therapeutic use (4) 4
breast-cancer (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
colorectal neoplasms - drug therapy (4) 4
etoposide - administration & dosage (4) 4
etoposide - adverse effects (4) 4
hypersensitivity reactions (4) 4
inhibitor (4) 4
leukopenia - chemically induced (4) 4
medicine & public health (4) 4
ovarian neoplasms - metabolism (4) 4
ovarian neoplasms - pathology (4) 4
paclitaxel - analogs & derivatives (4) 4
performance (4) 4
phase-ii (4) 4
survival (4) 4
tissue distribution (4) 4
3-hour infusion (3) 3
aged, 80 and over (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 24, Issue 3, pp. 467 - 475
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 1998, Volume 16, Issue 1, pp. 187 - 196
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 04/2001, Volume 12, Issue 4, pp. 315 - 323
Intravenous administration of paclitaxel is hindered by poor water solubility of the drug. Currently, paclitaxel is dissolved in a mixture of ethanol and... 
Phase 1 study | Pharmacokinetics | HPMA copolymers | Polymeric drug conjugates | Paclitaxel | PNU166945 | paclitaxel | NUDE-MICE | polymeric drug conjugates | CREMOPHOR-EL | TAXANES | CANCER | CHEMOTHERAPY | NONLINEAR PHARMACOKINETICS | THERAPY | ONCOLOGY | phase 1 study | pharmacokinetics | PHARMACOLOGY & PHARMACY | HYPERSENSITIVITY REACTIONS | GAMMA-SCINTIGRAPHY | CARCINOMA | Lung Neoplasms - drug therapy | Paclitaxel - chemical synthesis | Area Under Curve | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Male | Paclitaxel - pharmacokinetics | Prodrugs - chemistry | Taxoids - analogs & derivatives | Methacrylates - chemistry | Drug Carriers | Dose-Response Relationship, Drug | Paclitaxel - chemistry | Paclitaxel - toxicity | Adult | Female | Ovarian Neoplasms - drug therapy | Polymers - chemical synthesis | Carcinoma, Small Cell - drug therapy | Paclitaxel - analogs & derivatives | Solubility | Anemia - chemically induced | Breast Neoplasms - drug therapy | Remission Induction | Maximum Tolerated Dose | Prodrugs - pharmacokinetics | Polymers - pharmacokinetics | Polymers - toxicity | Prodrugs - toxicity | Skin Neoplasms - secondary | Prodrugs - chemical synthesis | Nervous System Diseases - chemically induced | Polymers - chemistry | Aged | Infusions, Intravenous | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2001, Volume 19, Issue 7, pp. 1893 - 1900
Journal Article
Journal Article
Journal Article
Journal Article